Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

about

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

Item

http://www.wikidata.org/entity/Q49678698

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Independent replication of pol ...... taining adjuvant chemotherapy.

@en

Independent replication of pol ...... taining adjuvant chemotherapy.

@nl

type

Item

label

Independent replication of pol ...... taining adjuvant chemotherapy.

@en

Independent replication of pol ...... taining adjuvant chemotherapy.

@nl

prefLabel

Independent replication of pol ...... taining adjuvant chemotherapy.

@en

Independent replication of pol ...... taining adjuvant chemotherapy.

@nl

P1476

Independent replication of pol ...... ntaining adjuvant chemotherapy

@en

P2093

Aart van Bochove

http://www.w3.org/2001/XMLSchema#string

Alex L T Imholz

http://www.w3.org/2001/XMLSchema#string

Annelot G J van Rossum

http://www.w3.org/2001/XMLSchema#string

Danielle McCool

http://www.w3.org/2001/XMLSchema#string

Elise van Leeuwen-Stok

http://www.w3.org/2001/XMLSchema#string

Hendrika M Oosterkamp

http://www.w3.org/2001/XMLSchema#string

Ingrid A M Mandjes

http://www.w3.org/2001/XMLSchema#string

Johanneke E A Portielje

http://www.w3.org/2001/XMLSchema#string

Marjanka K Schmidt

http://www.w3.org/2001/XMLSchema#string

Mark Opdam

http://www.w3.org/2001/XMLSchema#string

P2860

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1

Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment

Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).

Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients.

Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.

Detection of anthracycline-induced cardiotoxicity.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

P304

113531-113542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22697

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik van Werkhoven

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29371927

http://www.w3.org/2001/XMLSchema#string

P932

5768344

http://www.w3.org/2001/XMLSchema#string